Total Payments
$640.75
2024 Payments
$36.92
Companies
16
Transactions
46
Payment Breakdown by Category
Food & Beverage$640.75 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $640.75 | 46 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $186.33 | 16 | $0 (2022) |
| Amgen Inc. | $101.85 | 8 | $0 (2020) |
| IRONSHORE PHARMACEUTICALS INC. | $66.38 | 3 | $0 (2024) |
| Novo Nordisk Inc | $49.92 | 4 | $0 (2019) |
| Merck Sharp & Dohme LLC | $44.12 | 3 | $0 (2023) |
| Cranial Technologies, Inc | $30.85 | 2 | $0 (2024) |
| AbbVie Inc. | $23.01 | 1 | $0 (2021) |
| Corium, Inc. | $21.64 | 1 | $0 (2021) |
| Lilly USA, LLC | $20.14 | 1 | $0 (2020) |
| SANOFI PASTEUR INC. | $17.98 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36.92 | 2 | IRONSHORE PHARMACEUTICALS INC. ($23.29) |
| 2023 | $75.45 | 4 | Ironshore Pharmaceuticals Inc. ($43.09) |
| 2022 | $79.78 | 5 | Supernus Pharmaceuticals, Inc. ($33.94) |
| 2021 | $197.04 | 16 | Supernus Pharmaceuticals, Inc. ($152.39) |
| 2020 | $87.89 | 6 | Amgen Inc. ($51.28) |
| 2019 | $74.71 | 6 | Amgen Inc. ($27.50) |
| 2018 | $59.98 | 5 | Novo Nordisk Inc ($25.88) |
| 2017 | $28.98 | 2 | Cranial Technologies, Inc ($17.22) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/25/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $13.63 | General |
| Category: Cranial Orthotic | ||||||
| 01/18/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $23.29 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 08/11/2023 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $22.21 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 06/15/2023 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $20.88 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 05/09/2023 | Merck Sharp & Dohme LLC | VAXELIS (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: VACCINE | ||||||
| 01/19/2023 | Merck Sharp & Dohme LLC | ROTATEQ (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: VACCINE | ||||||
| 09/14/2022 | Boston Scientific Corporation | General - Vascular Intervention (Device) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: General - Vascular Intervention_PI | ||||||
| 08/09/2022 | SANOFI PASTEUR INC. | VAXELIS (Biological), QUADRACEL, MENQUADFI | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Vaccines | ||||||
| 08/08/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $15.06 | General |
| Category: PSYCHOLOGY | ||||||
| 05/02/2022 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: ADHD | ||||||
| 02/02/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| Category: PSYCHOLOGY | ||||||
| 12/09/2021 | Corium, Inc. | Azstarys (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/03/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $12.60 | General |
| Category: PSYCHOLOGY | ||||||
| 11/03/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $13.09 | General |
| Category: PSYCHOLOGY | ||||||
| 10/20/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $16.49 | General |
| Category: PSYCHOLOGY | ||||||
| 10/08/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $7.80 | General |
| Category: PSYCHOLOGY | ||||||
| 09/21/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $12.69 | General |
| Category: PSYCHOLOGY | ||||||
| 09/21/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $4.50 | General |
| Category: PSYCHOLOGY | ||||||
| 09/14/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $5.65 | General |
| Category: PSYCHOLOGY | ||||||
| 08/24/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $7.20 | General |
| Category: PSYCHOLOGY | ||||||
| 08/10/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $9.26 | General |
| Category: PSYCHOLOGY | ||||||
| 08/06/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $10.93 | General |
| Category: PSYCHOLOGY | ||||||
| 07/23/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $15.64 | General |
| Category: PSYCHOLOGY | ||||||
| 05/28/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $16.64 | General |
| Category: PSYCHOLOGY | ||||||
| 05/07/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $16.26 | General |
| Category: PSYCHOLOGY | ||||||
About Dr. Jessica Easterling, M.D
Dr. Jessica Easterling, M.D is a Sports Medicine healthcare provider based in Shelbyville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1669656849.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jessica Easterling, M.D has received a total of $640.75 in payments from pharmaceutical and medical device companies, with $36.92 received in 2024. These payments were reported across 46 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($640.75).
Ad
Practice Information
- Specialty Sports Medicine
- Other Specialties Pediatrics
- Location Shelbyville, KY
- Active Since 12/23/2007
- Last Updated 02/14/2024
- Taxonomy Code 2080S0010X
- Entity Type Individual
- NPI Number 1669656849
Products in Payments
- QELBREE (Drug) $186.33
- Aimovig (Biological) $90.31
- JORNAY PM (Drug) $66.38
- VAXELIS (Biological) $35.66
- Doc Band (Device) $30.85
- Ozempic (Drug) $25.53
- HUMIRA (Biological) $23.01
- Azstarys (Drug) $21.64
- BASAGLAR (Drug) $20.14
- Livalo (Drug) $16.47
- ROTATEQ (Biological) $14.68
- Dyanavel XR (Drug) $14.36
- General - Vascular Intervention (Device) $13.50
- Tresiba (Drug) $12.75
- LONHALA MAGNAIR (Drug) $11.81
- ZOSTAVAX (Biological) $11.76
- Victoza (Drug) $11.64
- Repatha (Biological) $11.54
- SPIRIVA RESPIMAT (Drug) $11.36
- ARNUITY (Drug) $11.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.